SCHEMBL939284

SCHEMBL939284

COc1cc(C)c(S(=O)(=O)N(C)c2nc3cccc(C(=O)N4CCC5(CC4)CCN(c4ccncc4)CC5)c3n2C)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 11/20 0.47
CYP3A4 P08684 10/20 0.47
CYP1A2 P05177 6/20 0.47
HIF1A Q16665 5/20 0.43
CYP2C9 P11712 10/20 0.42
TSHR P16473 7/20 0.42
SMN1; SMN2 Q16637 7/20 0.42
ALDH1A1 P00352 5/20 0.42
CYP2C19 P33261 4/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.40
GFER P55789 1/20 0.40
MAPK1 P28482 3/20 0.39
USP2 O75604 2/20 0.39
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940732 0.96 CYP3A4 (0.45) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL938616 0.84 CYP3A4 (0.54) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL939114 0.84 SLC6A9 (0.38) KMT2A
SCHEMBL940776 0.81 CYP2D6 (0.47) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL938881 0.81 CYP3A4 (0.47) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL939216 0.80 CYP3A4 (0.51) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL940099 0.80 CYP2D6 (0.46) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL939680 0.80 CYP2D6 (0.46) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL939069 0.79 CYP2D6 (0.46) CYP2D6CYP3A4CYP1A2HIF1ACYP2C9
SCHEMBL938282 0.79 DHODH (0.44) SMN1; SMN2ALDH1A1HPGDGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440542-B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2013-12-18 EP claimed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US claimed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US claimed
WO-2010142402-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2010-12-16 WO claimed
EP-2440542-B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2013-12-18 EP disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
EP-2440542-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2012-04-18 EP disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed
WO-2010142402-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles BDKRB1, BDKRB2, BRD1 CYP2D6 1223/4885CYP3A4 253/4885CYP1A2 902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.